These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8499132)
1. Trends in neuroblastoma in Great Britain: incidence and mortality, 1971-1990. Stiller CA Eur J Cancer; 1993; 29A(7):1008-12. PubMed ID: 8499132 [TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening. Honjo S; Doran HE; Stiller CA; Ajiki W; Tsukuma H; Oshima A; Coleman MP Int J Cancer; 2003 Feb; 103(4):538-43. PubMed ID: 12478672 [TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Spix C; Pastore G; Sankila R; Stiller CA; Steliarova-Foucher E Eur J Cancer; 2006 Sep; 42(13):2081-91. PubMed ID: 16919772 [TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease Registry. Cotterill SJ; Parker L; More L; Craft AW Med Pediatr Oncol; 2001 Jan; 36(1):231-4. PubMed ID: 11464892 [TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the Evaluation of Neuroblastoma Screening in Europe. Powell JE; Estève J; Mann JR; Parker L; Frappaz D; Michaelis J; Kerbl R; Mutz ID; Stiller CA Lancet; 1998 Aug; 352(9129):682-7. PubMed ID: 9728983 [TBL] [Abstract][Full Text] [Related]
7. Screening for neuroblastoma: a review of the evidence. Chamberlain J J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511 [TBL] [Abstract][Full Text] [Related]
8. A population-based study of neuroblastoma incidence, survival, and mortality in North America. Bernstein ML; Leclerc JM; Bunin G; Brisson L; Robison L; Shuster J; Byrne T; Gregory D; Hill G; Dougherty G J Clin Oncol; 1992 Feb; 10(2):323-9. PubMed ID: 1732433 [TBL] [Abstract][Full Text] [Related]
9. Incidence and mortality of neuroblastoma in Canada compared with other childhood cancers. Gao RN; Levy IG; Woods WG; Coombs BA; Gaudette LA; Hill GB Cancer Causes Control; 1997 Sep; 8(5):745-54. PubMed ID: 9328197 [TBL] [Abstract][Full Text] [Related]
10. An investigation of the epidemiology of neuroblastoma in children under the age of 15 years in England, Scotland and Wales. Innocent GT Comput Appl Biosci; 1992 Apr; 8(2):97-106. PubMed ID: 1591619 [TBL] [Abstract][Full Text] [Related]
11. Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan. Ioka A; Inoue M; Yoneda A; Nakamura T; Hara J; Hashii Y; Sakata N; Yamato K; Tsukuma H; Kawa K J Epidemiol; 2016; 26(4):179-84. PubMed ID: 26548355 [TBL] [Abstract][Full Text] [Related]
12. Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study. Stiller CA; Bayne AM; Chakrabarty A; Kenny T; Chumas P BMC Cancer; 2019 Feb; 19(1):139. PubMed ID: 30744596 [TBL] [Abstract][Full Text] [Related]
13. Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan. Ajiki W; Tsukuma H; Oshima A; Kawa K Cancer Causes Control; 1998 Dec; 9(6):631-6. PubMed ID: 10189049 [TBL] [Abstract][Full Text] [Related]
14. Effects of mass screening on age-specific incidence of neuroblastoma. Bessho F Int J Cancer; 1996 Aug; 67(4):520-2. PubMed ID: 8759611 [TBL] [Abstract][Full Text] [Related]
15. Survival of children with neuroblastoma. time trends and regional differences in Europe, 1978--1992. Spix C; Aareleid T; Stiller C; Magnani C; Kaatsch P; Michaelis J Eur J Cancer; 2001 Apr; 37(6):722-9. PubMed ID: 11311646 [TBL] [Abstract][Full Text] [Related]
16. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study. Shinagawa T; Kitamura T; Katanoda K; Matsuda T; Ito Y; Sobue T Int J Cancer; 2017 Feb; 140(3):618-625. PubMed ID: 27778323 [TBL] [Abstract][Full Text] [Related]
17. Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US. Panagopoulou P; Georgakis MK; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; Hatzipantelis E; Stiakaki E; Dana H; Tragiannidis A; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Gheorghiu R; Šekerija M; Trojanowski M; Žagar T; Zborovskaya A; Ryzhov A; Dessypris N; Morgenstern D; Petridou ET Eur J Cancer; 2018 Jun; 96():44-53. PubMed ID: 29673989 [TBL] [Abstract][Full Text] [Related]
18. Increasing incidence of neuroblastoma and potentially higher associated mortality of children from nonmetropolitan areas: analysis of the surveillance, epidemiology, and end results database. Hsieh MH; Meng MV; Walsh TJ; Matthay KK; Baskin LS J Pediatr Hematol Oncol; 2009 Dec; 31(12):942-6. PubMed ID: 19875967 [TBL] [Abstract][Full Text] [Related]
19. A population-based study of the usefulness of screening for neuroblastoma. Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429 [TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma screening data. An epidemiologic analysis. Goodman SN Am J Dis Child; 1991 Dec; 145(12):1415-22. PubMed ID: 1669671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]